Nomura Securities Reiterates Buy on Synchrony Financial (SYF) Following Better-Than-Expected Payout
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Nasdaq, S&P end lower as tech stocks fall
- Micron posts record profit as AI memory demand fuels explosive growth
- Brent settles at lowest since before start of Iran war as more tankers exit Hormuz
- All eyes on Micron earnings tonight as sell-off raises stakes for AI memory trade
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Rescue work underway after quakes rock Venezuela, 'high casualties' likely
- Needham Starts NeoVolta (NEOV) at Buy
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
Synchrony Financial (SYF): Capital Plan Larger Than Expected - Jefferies
July 8, 2016 8:28 AM EDTJefferies analyst, John Hecht, reiterated his Buy rating on Synchrony Financial (NYSE: SYF) after announcing its capital plan for the next 4 quarters. The total payout of ~$1.38B, nearly 60% of forecasted CY16 income, is modestly ahead of expectations.
The total annual dividend of $0.52 compares... More
BTIG Affirms Synchrony Financial (SYF) at 'Buy' as New Catalyst Appears
July 8, 2016 8:10 AM EDTBTIG affirms Synchrony Financial (NYSE: SYF) with a Buy rating and $42 price target following the company's announcement... More
After-Hours Stock Movers 07/07: (CUDA) (GPS) (SYF) Higher; (JUNO) (KITE) (PSMT) Lower (more...)
July 7, 2016 6:00 PM EDTToday's After-Hours Movers
Juno Therapeutics' (NASDAQ: JUNO) 27.2% LOWER; announced that it has received notice from the U.S. Food and Drug Administration (FDA) that a clinical hold has been placed on the Phase II clinical trial of JCAR015 in adult patients with relapsed or refractory B cell acute lymphoblastic leukemia (r/r ALL), known as the ROCKET trial. The clinical hold was initiated after two patient deaths last... More
Synchrony Financial (SYF) Declares $0.13 Quarterly Dividend; $952M Buyback
July 7, 2016 5:30 PM EDTSynchrony Financial (NYSE: SYF) declared a quarterly dividend of $0.13 per share, or $0.52 annualized.
The dividend will be payable on August 25, 2016, to stockholders of record on August 12, 2016, with an ex-dividend date of August 10, 2016.
The annual yield on the dividend is 2... More
